Your browser doesn't support javascript.
loading
Sponsored multicentric clinical research conducted in Brazil in the respiratory area - losses and gains.
Carvalho, Andréa Kelly da Silveira; Nascimento, Oliver Augusto; Fonseca, Marcelo Cunio Machado; Pereira, Eanes Delgado Barros; Jardim, José Roberto.
Afiliação
  • Carvalho AK; Graduate Program in Cardiorespiratory Physiotherapy, Universidade de Fortaleza, Fortaleza, CE, Brazil.
  • Nascimento OA; Pulmonology Department, Universidade Federal de São Paulo, São Paulo, SP, Brazil.
  • Fonseca MC; Unifesp, São Paulo, SP, Brazil.
  • Pereira ED; Internal Medicine Department, Universidade Federal do Ceará, Fortaleza, CE, Brazil.
  • Jardim JR; Escola Paulista de Medicina, Unifesp, São Paulo, SP, Brazil.
Rev Assoc Med Bras (1992) ; 62(2): 131-7, 2016 Apr.
Article em En | MEDLINE | ID: mdl-27167542
OBJECTIVE: To evaluate the sponsored centers for clinical trial in the respiratory care setting in Brazil: profile; logistics and structure. METHODS: Principal investigators (29) and subinvestigators (30) of 39 research centers completed the questionnaires that addressed personal identification and training of researchers, the centers' facilities and advantages and/or disadvantages of performing sponsored trials. RESULTS: 75.6% of the centers were located in southern and southeastern Brazil. Most principal investigators were men with a mean age of 53.4 years. The clinical trials in the respiratory care setting focus on asthma and chronic obstructive pulmonar disease (COPD). 80% of the researchers cited delay of the Conep and Anvisa as a barrier to performing research. The advantages of participating in clinical trials were updating knowledge of the researcher and the team, and additional income for the team. The main disadvantages mentioned by the researchers included low financial compensation for the performed workload, and time availability. The median number of professionals per research center was six people, predominantly physicians. CONCLUSION: The number of research centers in the respiratory care setting in Brazil is still relatively small. The teams have good training for performing the clinical trials. Asthma and COPD are the most studied diseases in sponsored clinical trials. The main barrier is delay by the Conep and Anvisa. The factors that lead investigators to participate range from being updated along with the team, to site and staff financial issues; the main disadvantage is the low compensation for the required workload demand.
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pesquisadores / Apoio à Pesquisa como Assunto / Ensaios Clínicos como Assunto / Estudos Multicêntricos como Assunto / Pesquisa Biomédica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Rev Assoc Med Bras (1992) Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pesquisadores / Apoio à Pesquisa como Assunto / Ensaios Clínicos como Assunto / Estudos Multicêntricos como Assunto / Pesquisa Biomédica Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: America do sul / Brasil Idioma: En Revista: Rev Assoc Med Bras (1992) Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Brasil País de publicação: Brasil